Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.7371
-0.0467 (-5.96%)
At close: Aug 26, 2026, 4:00 PM EDT
0.7350
-0.0021 (-0.28%)
Pre-market: Aug 27, 2026, 7:06 AM EDT

Fractyl Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
--0.090.12--
Revenue Growth
---22.50%---
Cost of Revenue
--0.050.08--
Gross Profit
--0.040.04--
Selling, General & Admin
22.5322.2823.112.8415.0310.49
Research & Development
63.3674.5470.4738.0434.3526.44
Operating Expenses
85.8996.8293.5750.8849.3936.93
Operating Income
-85.89-96.82-93.53-50.84-49.39-36.93
Interest Expense
------1.46
Interest & Investment Income
1.841.544.151.260.80.02
Other Non Operating Income (Expenses)
-16.83-40.9517.86-6.820.13-0.37
EBT Excluding Unusual Items
-100.89-136.23-71.52-56.39-48.46-38.74
Other Unusual Items
-4.76-4.722.83-20.72-
Pretax Income
-105.65-140.95-68.69-77.09-46.45-38.74
Net Income
-105.65-140.95-68.69-77.09-46.45-38.74
Preferred Dividends & Other Adjustments
--1.7417.1817.1814.49
Net Income to Common
-105.65-140.95-70.43-94.27-63.63-53.22
Net Income Growth
------
Shares Outstanding (Basic)
1317644222
Shares Outstanding (Diluted)
1317644222
Shares Change
168.74%74.13%1992.01%4.57%7.03%0.90%
EPS (Basic)
-0.81-1.86-1.62-45.29-31.97-28.62
EPS (Diluted)
-0.81-1.86-1.62-45.29-31.97-28.62
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-82.44-90.89-67.29-43.18-46.3-33.51
Free Cash Flow Per Share
-0.63-1.20-1.54-20.75-23.26-18.02
Gross Margin
--46.24%35.83%--
Operating Margin
---100570.97%-42363.33%--
Profit Margin
---75732.26%-78559.17%--
Free Cash Flow Margin
---72350.54%-35985.00%--
EBITDA
-84.77-95.69-92.85-50.55-48.93-36.25
D&A For EBITDA
1.131.130.680.290.450.68
EBIT
-85.89-96.82-93.53-50.84-49.39-36.93
SEC Filings: 10-K · 10-Q